Literature DB >> 2554124

Transient changes in cyclic AMP and in the enzymic activity of protein kinase and phosphorylase during the cardiac cycle in the canine myocardium and the effect of propranolol.

E G Krause1, S Bartel, I Beyerdörfer, W Freier, K Gerber, D Obst.   

Abstract

Oscillation of cyclic AMP and in the activity ratio of cyclic AMP-dependent protein kinase and of glycogen phosphorylase with the cardiac cycle were demonstrated in the canine heart in situ. For tissue sampling an ECG (R-wave)-triggered, automatically working push-freeze-drill apparatus was developed which allows intraventricular cryobiopsies from the left ventricular muscle of anaesthetized open-chest dogs. The nucleotide cyclic AMP oscillated with the cardiac cycle during normal working condition, the higher cyclic AMP level occuring during systole. Cyclic GMP was assayed to be without oscillatory changes during the contraction-relaxation cycle. The rise in the activity ratio of protein kinase was found to coincide with the maximum in the level of cyclic AMP. Propranolol pretreatment prevents the transient in the level of the nucleotide as well as in the activity ratio of the kinase indicating i) a causal relationship between these changes and ii) a neurohumoral, beat-to-beat regulation by catecholamines released from the sympathetic nerve endings within the heart. Contrary the activity ratio of phosphorylase retains its transient changes during the cardiac cycle in the presence of propranolol, indicating a Ca-mediated activation of phosphorlase kinase during the contraction process.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554124     DOI: 10.1007/BF00220773

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  16 in total

1.  Regulation of adenosine 3:5-monophosphate-dependent protein kinase.

Authors:  S L Keely; J D Corbin; C R Park
Journal:  J Biol Chem       Date:  1975-07-10       Impact factor: 5.157

2.  Ca2+ transport by mammalian mitochondria and its role in hormone action.

Authors:  R M Denton; J G McCormack
Journal:  Am J Physiol       Date:  1985-12

3.  Effects of adrenaline and methylisobutylxanthine on adenosine 3':5'-monophosphate levels in cultures of beating heart cells of the newborn rat.

Authors:  A Wollenberger; R Irmler
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1976 May 26-29

4.  Cyclic changes in levels of cyclic AMP and cyclic GMP in frog myocardium during the cardiac cycle.

Authors:  A Wollenberger; E B Babskii; E G Krause; S Genz; D Blohm; E V Bogdanova
Journal:  Biochem Biophys Res Commun       Date:  1973-11-16       Impact factor: 3.575

5.  Cyclic 3',5'-nucleotide phosphodiesterase, IV. Two enzymes with different properties from brain.

Authors:  S Kakiuchi; R Yamazaki; Y Teshima
Journal:  Biochem Biophys Res Commun       Date:  1971-03-05       Impact factor: 3.575

6.  Calcium dependent regulation of brain and cardiac muscle adenylate cyclase.

Authors:  J D Potter; M T Piascik; P L Wisler; S P Robertson; C L Johnson
Journal:  Ann N Y Acad Sci       Date:  1980       Impact factor: 5.691

7.  Changes in adenosine and glycogen phosphorylase activity during the cardiac cycle.

Authors:  C I Thompson; R Rubio; R M Berne
Journal:  Am J Physiol       Date:  1980-03

8.  Oscillation of cyclic adenosine monophosphate concentration during the myocardial contraction cycle.

Authors:  G Brooker
Journal:  Science       Date:  1973-11-20       Impact factor: 47.728

9.  Cyclic nucleotides and changes in protein kinase activity ratio in the ischemic and nonischemic myocardium.

Authors:  E G Krause; S Bartel; P Karczewski; K F Lindenau
Journal:  Adv Myocardiol       Date:  1983

10.  Rhythmic change of myocardial phosphate metabolite content in cardiac cycle observed by depth-selected and EKG-gated in vivo 31P-NMR spectroscopy in a whole animal.

Authors:  T Toyo-oka; K Nagayama; M Umeda; K Eguchi; S Hosoda
Journal:  Biochem Biophys Res Commun       Date:  1986-03-28       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.